Ben Zichri-David S, Shkuri L, Ast T
NPJ Metab Health Dis. 2025; 3(1):6.
PMID: 40052109
PMC: 11879881.
DOI: 10.1038/s44324-024-00045-y.
Gao Q, Zhou Y, Chen Y, Hu W, Jin W, Zhou C
Ann Med. 2025; 57(1):2472871.
PMID: 40038870
PMC: 11884104.
DOI: 10.1080/07853890.2025.2472871.
Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J
Bone Res. 2025; 13(1):27.
PMID: 40000618
PMC: 11861620.
DOI: 10.1038/s41413-024-00398-6.
Morishima T, Fakruddin M, Kanamori Y, Masuda T, Ogawa A, Wang Y
Sci Adv. 2025; 11(8):eadu3011.
PMID: 39983002
PMC: 11844735.
DOI: 10.1126/sciadv.adu3011.
Cancado R, Leite L, Munoz M
Diagnostics (Basel). 2025; 15(3).
PMID: 39941219
PMC: 11817370.
DOI: 10.3390/diagnostics15030289.
Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway.
Xie X, Chang L, Zhu X, Gong F, Che L, Zhang R
Int J Mol Sci. 2025; 26(3).
PMID: 39941155
PMC: 11818739.
DOI: 10.3390/ijms26031385.
Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases.
Wang Z, Wu C, Yin D, Dou K
Cardiovasc Diabetol. 2025; 24(1):60.
PMID: 39920799
PMC: 11806630.
DOI: 10.1186/s12933-025-02614-x.
Genetic Markers of Postmortem Brain Iron.
Cornelis M, Fazlollahi A, Bennett D, Schneider J, Ayton S
J Neurochem. 2025; 169(2):e16309.
PMID: 39918201
PMC: 11804167.
DOI: 10.1111/jnc.16309.
Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner.
Qian X, Zhou Q, Ouyang Y, Wu X, Sun X, Wang S
Proc Natl Acad Sci U S A. 2025; 122(5):e2412473122.
PMID: 39888917
PMC: 11804496.
DOI: 10.1073/pnas.2412473122.
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.
Imam M, Ji J, Zhang Z, Yan S
Front Pharmacol. 2025; 15:1493188.
PMID: 39867656
PMC: 11757020.
DOI: 10.3389/fphar.2024.1493188.
Ferritin as an Effective Prognostic Factor and Potential Cancer Biomarker.
Szymulewska-Konopko K, Reszec-Gielazyn J, Maleczek M
Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852175
PMC: 11763953.
DOI: 10.3390/cimb47010060.
Regulation and therapy: the role of ferroptosis in DLBCL.
Wang Y, He Z, Dong X, Yao Y, Chen Q, Shi Y
Front Pharmacol. 2025; 15():1458412.
PMID: 39834804
PMC: 11743434.
DOI: 10.3389/fphar.2024.1458412.
A Brief History of Ferritin, an Ancient and Versatile Protein.
Arosio P, Cairo G, Bou-Abdallah F
Int J Mol Sci. 2025; 26(1.
PMID: 39796064
PMC: 11719527.
DOI: 10.3390/ijms26010206.
Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-β Precursor Protein in Alzheimer's Disease.
Khan M
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770511
PMC: 11677800.
DOI: 10.3390/ph17121669.
Sex and Gender Differences in Iron Chelation.
Allegra S, Comita S, Roetto A, De Francia S
Biomedicines. 2025; 12(12.
PMID: 39767791
PMC: 11673655.
DOI: 10.3390/biomedicines12122885.
In defence of ferroptosis.
Alves F, Lane D, Nguyen T, Bush A, Ayton S
Signal Transduct Target Ther. 2025; 10(1):2.
PMID: 39746918
PMC: 11696223.
DOI: 10.1038/s41392-024-02088-5.
Inverted U-Shaped Association of Soluble Transferrin Receptor Concentrations with Risks of Cardiovascular Diseases in Overweight Individuals: A Cross-Sectional Study.
Hu X, Xu J, Gu Y
Rev Cardiovasc Med. 2025; 25(12):439.
PMID: 39742215
PMC: 11683708.
DOI: 10.31083/j.rcm2512439.
Physical Activity Reduces Metabolic Risk via Iron Metabolism: Cross-National Evidence Using the Triglyceride-Glucose Index.
Hao Z, Guo X, Wang Y, Yang G
Metabolites. 2024; 14(12).
PMID: 39728432
PMC: 11676255.
DOI: 10.3390/metabo14120651.
Decoding ferroptosis: transforming orthopedic disease management.
Huo G, Lin Y, Liu L, He Y, Qu Y, Liu Y
Front Pharmacol. 2024; 15:1509172.
PMID: 39712490
PMC: 11659002.
DOI: 10.3389/fphar.2024.1509172.
Novel loci and biomedical consequences of iron homoeostasis variation.
Allara E, Bell S, Smith R, Keene S, Gill D, Gaziano L
Commun Biol. 2024; 7(1):1631.
PMID: 39643614
PMC: 11624196.
DOI: 10.1038/s42003-024-07115-3.